0001209191-17-057667.txt : 20171020 0001209191-17-057667.hdr.sgml : 20171020 20171020172329 ACCESSION NUMBER: 0001209191-17-057667 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171018 FILED AS OF DATE: 20171020 DATE AS OF CHANGE: 20171020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pope Todd CENTRAL INDEX KEY: 0001584367 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 171147720 MAIL ADDRESS: STREET 1: C/O TRANSENTERIX STREET 2: 635 DAVIS DRIVE, SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27713 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSENTERIX INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-10-18 0 0000876378 TRANSENTERIX INC. TRXC 0001584367 Pope Todd C/O TRANSENTERIX, INC. 635 DAVIS DRIVE, SUITE 300 MORRISVILLE NC 27560 1 1 0 0 President and CEO Common Stock 2017-10-18 4 M 0 95335 0.35 A 462644 D Common Stock 2017-10-18 4 M 0 287356 0.35 A 750000 D Common Stock 2017-10-18 4 S 0 600000 3.68 D 150000 D Stock Option 0.35 2017-10-18 4 M 0 95335 0.00 D 2013-12-14 2019-12-14 Common Stock 95335 0 D Stock Option 0.35 2017-10-18 4 M 0 287356 0.00 D 2015-02-02 2022-04-12 Common Stock 287356 138555 D The identified transactions set forth on this Form 4 were made pursuant to a Rule 10b5-1(c) sales plan executed by the reporting person on August 9, 2017, as amended. The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.46 to $4.23 inclusive. The reporting person undertakes to provide to TransEnterix, Inc., any security holder of TransEnterix, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. /s/ Joshua Weingard as attorney-in-fact for Todd M Pope 2017-10-20